SE8205533L - Forfarande for framstellning av aminoalkylfuranderivat med terapeutisk verkan - Google Patents

Forfarande for framstellning av aminoalkylfuranderivat med terapeutisk verkan

Info

Publication number
SE8205533L
SE8205533L SE8205533A SE8205533A SE8205533L SE 8205533 L SE8205533 L SE 8205533L SE 8205533 A SE8205533 A SE 8205533A SE 8205533 A SE8205533 A SE 8205533A SE 8205533 L SE8205533 L SE 8205533L
Authority
SE
Sweden
Prior art keywords
group
denotes
formula
alk
alkyl
Prior art date
Application number
SE8205533A
Other languages
English (en)
Other versions
SE8205533D0 (sv
SE454882B (sv
Inventor
B J Price
J W Clitherow
J Bradshaw
Original Assignee
Allen & Hanburys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27448487&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8205533(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB32465/76A external-priority patent/GB1565966A/en
Priority claimed from KR7701808A external-priority patent/KR810000355B1/ko
Application filed by Allen & Hanburys Ltd filed Critical Allen & Hanburys Ltd
Publication of SE8205533L publication Critical patent/SE8205533L/sv
Publication of SE8205533D0 publication Critical patent/SE8205533D0/sv
Publication of SE454882B publication Critical patent/SE454882B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/64—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Claims (1)

Patentkrav
1. Firfarande fir framstallning as fbreningar med den formeln R2 N-A 1k0' (CH2)nX(CH2)mNHCNHR3 samt fysiologiskt godtagbara salter soh N-oxider och hydrat darav, dar symbolerna RI och g2, mom kan vara like eller alike, vardera betecknar en vateatom, en lagalkygrupp, en cykoalkylgrupp, en lAgalkenylgrupp, en aralky]grupp eller en lagalkylgrupp avbruten as en syreatom eller en grupp, dar 114betecknar , site eller lagalkyl, eller • A4 dar symbolerna Ri och R2 tillsammans med den kvaveatom, till silken de Ur bundna, bildar on heterocyklisk ring, vilken dessutom ken innehalla en syreatom eller en grupp -114-; dar 113 betecknar en vateatom, en lagal- Ry kylgrupp, en V',galkenylgrupp eller en alkoxialkylgrupp; (tar X betecknar 0112, 0 eller 8; dar Ytecknar =S, NR eller -CRR6; dar Alk be- teeknar en rak ellerrenad alkyle.la innehtillande 1-6 kolatomer; underkastas en Mannich-reaktion med en 1iimplig aldehyd och en sekundar amin eller ett salt as en primal, amin eller en sekundar amin till bild,ning as foreningar med formeln I, dar Y betecknar en =11I och Alk betecknar an metylengrupp eller enjargrenad alkylengrupp; eller alt (f) en farening med formein N17-Alk 410,3_ (C11)X(C112)NCI(IV) dar R1 R. •och n har de oven angivna betydelserna, omsatten , 2 Alk X, m med en amin med formeln 11311H2, clar R3 bar oVan anglers betydelse, till bildning as foreningar med fcrmeln I, dir Y betecknar svavel; varvid 1 samtliga fall slutprodukten eventuellt isoleras Sa50M ett fysiologiskt godtagbart salt eller omvandlas frdn ett dylikt salt till ett annat. allmanna (I) RI -oi- 1 7 dar R. betecknar en vgteatoM, en nitrogrupp, en cyangrupp, en lfigalkyi. grupp, en arylgrupp, en alkylsulfonylgrupp eller en arylsulfonylgrupp; dgr 26 betecknar en nitrogrupp, en arylsulfonylgrupp eller en alkylsulfonylgrupp; ddr m betecknar ett heltal frgn 2 till 4 och db.r n betecknar 1 eller 2, eller dal n betecknar 0,1 eller 2 ngr X betecknar 3 elier CE2; med den begrgnsningen att Y joke ban beteckna gruppen CHNO2 ngr R2, R2 och R3 betecknar metyl, Alk betecknar metylen, X betecknar S,nbetecknar 1 ochmbetecknar 2,1<11nnetec1
SE8205533A 1976-08-04 1982-09-28 Forfarande for framstellning av aminoalkylfuranderivat med terapeutisk verkan SE454882B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB32465/76A GB1565966A (en) 1976-08-04 1976-08-04 Aminoalkyl furan derivatives
GB5068576 1976-12-06
GB2018777 1977-05-13
KR7701808A KR810000355B1 (ko) 1977-05-13 1977-08-04 아미노 알킬푸란 유도체의 제조방법

Publications (3)

Publication Number Publication Date
SE8205533L true SE8205533L (sv) 1982-09-28
SE8205533D0 SE8205533D0 (sv) 1982-09-28
SE454882B SE454882B (sv) 1988-06-06

Family

ID=27448487

Family Applications (3)

Application Number Title Priority Date Filing Date
SE7708521A SE437373B (sv) 1976-08-04 1977-07-25 Forfarande for framstellning av ett aminoalkylfuranderivat med terapeutisk verkan
SE8205533A SE454882B (sv) 1976-08-04 1982-09-28 Forfarande for framstellning av aminoalkylfuranderivat med terapeutisk verkan
SE8206556A SE454883B (sv) 1976-08-04 1982-11-17 Aminoalkylfuranderivat till anvendning som mellanprodukter vid framstellning av aminoalkylfuranderivat med terapeutisk verkan

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7708521A SE437373B (sv) 1976-08-04 1977-07-25 Forfarande for framstellning av ett aminoalkylfuranderivat med terapeutisk verkan

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8206556A SE454883B (sv) 1976-08-04 1982-11-17 Aminoalkylfuranderivat till anvendning som mellanprodukter vid framstellning av aminoalkylfuranderivat med terapeutisk verkan

Country Status (16)

Country Link
AT (1) AT375931B (sv)
CH (2) CH642072A5 (sv)
CY (1) CY1077A (sv)
DE (2) DE2759959C2 (sv)
DK (2) DK148258C (sv)
ES (2) ES461334A1 (sv)
FI (1) FI72318C (sv)
HK (1) HK55780A (sv)
IE (1) IE45456B1 (sv)
IT (2) IT1126759B (sv)
KE (1) KE3080A (sv)
NZ (2) NZ191383A (sv)
PH (1) PH13540A (sv)
PT (1) PT66874B (sv)
SE (3) SE437373B (sv)
YU (2) YU40006B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4203909A (en) * 1978-09-26 1980-05-20 Bristol-Myers Company Furan compounds
YU52598A (sh) * 1998-11-19 2001-05-28 D.D. Zdravlje- sektor za istraživanje i razvoj POSTUPAK ZA sintezu N-[2[[[5=[(DIALKILAMINO)METIL]-2= FURANIL]METIL]TIO]ETIL]-N'-ALKIL-2-NITRO 1,1 ALKENDIAMINA I NJIHOVIH HIDROHLORIDA

Also Published As

Publication number Publication date
ES461334A1 (es) 1979-05-16
NZ184759A (en) 1980-09-12
SE454883B (sv) 1988-06-06
YU40006B (en) 1985-06-30
PH13540A (en) 1980-06-26
DK148258C (da) 1985-10-14
YU200082A (en) 1983-01-21
DK149952B (da) 1986-11-03
ES470836A1 (es) 1979-02-16
KE3080A (en) 1980-10-03
NZ191383A (en) 1980-09-12
SE7708521L (sv) 1978-02-05
AT375931B (de) 1984-09-25
DE2760097C2 (sv) 1989-08-17
PT66874B (en) 1979-01-23
DK416384A (da) 1984-08-30
IT1126759B (it) 1986-05-21
IE45456B1 (en) 1982-08-25
FI72318C (sv) 1987-05-11
CH642072A5 (en) 1984-03-30
IT8548437A0 (it) 1985-08-01
PT66874A (en) 1977-09-01
HK55780A (en) 1980-10-10
ATA574077A (de) 1984-02-15
DK337977A (da) 1978-02-05
CY1077A (en) 1980-12-27
FI772264A (sv) 1978-02-05
YU191177A (en) 1983-01-21
SE8206556D0 (sv) 1982-11-17
SE437373B (sv) 1985-02-25
DK148258B (da) 1985-05-20
IE45456L (en) 1978-02-04
CH641176A5 (en) 1984-02-15
SE8206556L (sv) 1982-11-17
DK149952C (da) 1987-07-06
SE8205533D0 (sv) 1982-09-28
IT1221058B (it) 1990-06-21
DE2759959C2 (sv) 1988-08-04
DK416384D0 (da) 1984-08-30
YU40088B (en) 1985-06-30
FI72318B (fi) 1987-01-30
SE454882B (sv) 1988-06-06

Similar Documents

Publication Publication Date Title
US3763156A (en) 2-heterocyclic amino-4-morpholinothieno(3,2-d)pyrimidines
AU668901B2 (en) Piperazine derivatives as 5-HT receptors antagonists
AU594739B2 (en) Thieno-1,4-diazepines
AU2001272476A1 (en) Piperidines for use as orexin receptor antagonists
IE41539L (en) Chroman derivatives.
KR830009773A (ko) 1,2-디아미노 시클로부텐-3,4-디온의 제조방법
KR840004107A (ko) 1,4-디히드로피리딘-3,5-디카르복실산 에스테르 유도체의 제법
ATE26263T1 (de) 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepine, verfahren zur herstellung derselben und ihre verwendung als heilmittel.
KR830000694A (ko) 헤테로싸이클 유도체의 제조방법
ES8207151A1 (es) Un procedimiento para la pre-paracion de imidazolilfenilami-dinas.
EP0000220A1 (de) Dihydrouracile, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
AU644295B2 (en) 2-aminopyrimidine-4-carboxamide derivatives, their preparation and their use in therapeutics
AU8696182A (en) 1-phenyl-2-aminocarbonylindole compounds
KR880001988B1 (ko) 헤테로사이클릭 화합물의 제조방법
SE8205533L (sv) Forfarande for framstellning av aminoalkylfuranderivat med terapeutisk verkan
IE782028L (en) Substituted furans
ES486071A1 (es) Un procedimiento para la preparacion de derivados de amina
US3396165A (en) 9-aminomethyl-3, 8-diloweralkyl-10-hydroxy-5-oxo-1, 2, 3, 4-tetrahydrobenzopyrano [3,4-c] pyridines
ES403486A1 (es) Procedimiento para la preparacion de derivados de piperazi-na.
ATE42295T1 (de) Penem-derivate, verfahren zu deren herstellung, ihre verwendung und pharmazeutische zusammensetzungen.
KR860002507A (ko) 치환 7-옥소미토산의 제조방법
DE3164667D1 (en) Amino-alcoxy pyrazoles, process for their preparation and medicaments containing them
DE3689762T2 (de) Antibakterielle Verbindungen, ihre Herstellung und Verwendung.
DE2430454A1 (de) Neue pyrazolo eckige klammer auf 3,4d eckige klammer zu pyrimidine
NO844778L (no) Fremgangmsmaate for fremstilling av 2-hydroksy-propiofenom-derivater

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8205533-6

Effective date: 19930204

Format of ref document f/p: F